V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005378 | 280007826 | 1.57 | 57.4 | Palliative (P) | 2013-01-05 | 2013-01-05 | GemCarbo Days 1+8 | Y | Y | 280028996 | GEMCARBO |
| 280005379 | 280007826 | 1.59 | 61.6 | Curative (C) | 2013-06-28 | 2013-08-12 | Rituximab | N | N | 280028996 | FCR |
| 280005380 | 280007826 | 1.74 | 83 | Palliative (P) | 2014-12-27 | 2014-12-27 | CISPLATIN + ETOPOSIDE | 2 | N | 280028996 | OCTREOTIDE |
| 280005381 | 280007826 | 1.59 | 61.8 | null | 2016-10-13 | 2016-10-13 | GEDDIS TRIAL | 02 | null | 280028996 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE |
| 280005382 | 280007826 | 1.63 | 79 | Adjuvant (A) | 2015-11-04 | 2015-11-17 | Carbo F | 02 | N | 280028996 | OXALIPLATIN + MDG |
| 280005383 | 280003452 | 1.56 | 71.8 | Palliative (P) | 2016-04-26 | 2016-04-26 | Doxorubicin + Olaratumab | 02 | N | 280029005 | DABRAFENIB |
| 280005384 | 280003452 | 1.75 | 106 | null | 2015-04-15 | 2015-04-22 | FEC 60 or 75 | N | N | 280029005 | ECX |
| 280005385 | 280003452 | 1.83 | null | null | 2017-10-29 | 2017-11-16 | Ipilimumab | N | N | 280029005 | VEMURAFENIB |
| 280005386 | 280003453 | null | 61.5 | Curative (C) | 2018-01-25 | 2018-01-26 | VIDE | 02 | N | 280029009 | BCG |
| 280005387 | 280003453 | 1.69 | 69 | null | 2014-11-19 | 2014-12-05 | GEMCITABINE | N | N | 280029009 | MITOMYCIN INTRAVESICULAR |
| 280005388 | 280003454 | 1.73 | 82.2 | Palliative (P) | 2018-05-17 | 2018-05-18 | Trabectedin | 02 | N | 280029012 | BENDAMUSTINE + RITUXIMAB |
| 280005389 | 280003455 | 1.97 | 92 | Palliative (P) | 2018-03-29 | 2018-03-31 | CAPECITABINE + OXALIPLATIN | N | N | 280029014 | CARBOPLATIN + LIPOSOMAL DOX |
| 280005390 | 280003455 | 1.63 | 4.1 | Palliative (P) | 2016-07-19 | 2016-07-21 | Ipilimumab | N | N | 280029014 | OCTREOTIDE |
| 280005391 | 280003455 | 1.76 | null | Palliative (P) | 2016-08-22 | 2016-08-22 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280029014 | GEMCARBO |
| 280005392 | 280011070 | 1.8 | 91.7 | Palliative (P) | 2016-10-27 | 2016-11-08 | Ipilimumab | 02 | N | 280029021 | CAPECITABINE + STREPTOZOCIN |
| 280005393 | 280011070 | 1.6 | 104 | Palliative (P) | 2014-04-15 | 2014-04-15 | Doxorubicin + Olaratumab | N | N | 280029021 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005394 | 280011070 | 1.7 | null | null | 2017-06-09 | 2017-07-03 | CYCLOPHOSPHAMIDE + VINORELBINE | 02 | Y | 280029021 | GEMCARBO |
| 280005395 | 280011070 | 1.87 | 0 | Palliative (P) | 2014-07-31 | 2014-08-07 | Doxorubicin + Olaratumab | N | N | 280029021 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN |
| 280005396 | 280011070 | null | 78.7 | Curative (C) | 2015-06-21 | 2015-07-03 | EW EuroEwing 99 : VIDE | null | null | 280029021 | CAPECITABINE + OXALIPLATIN |
| 280005397 | 280003456 | 1.57 | 71.4 | Palliative (P) | 2014-10-28 | 2014-11-01 | Oxaliplatin + Modified de Gramont | N | N | 280029029 | GEMCARBO |
| 280005398 | 280003456 | 0 | 66.1 | Palliative (P) | 2015-01-08 | 2015-01-15 | Dacarbazine | N | N | 280029029 | GEMCARBO |
| 280005399 | 280003457 | 1.6 | 78 | Palliative (P) | null | 2018-08-28 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280029033 | CISPLATIN + PEMETREXED |
| 280005400 | 280003457 | 1.58 | 67.7 | Curative (C) | 2014-07-20 | 2014-08-01 | GEMCARBO | N | N | 280029033 | BEP |
| 280005401 | 280003458 | null | 100 | Palliative (P) | 2015-05-02 | 2015-05-19 | Irinotecan + Modified De Gramont | N | null | 280029038 | CISPLATIN + ETOPOSIDE |
| 280005402 | 280003458 | 1.7 | 80.6 | Curative (C) | 2014-04-07 | 2014-04-25 | CEDIRANIB | 2 | N | 280029038 | FLUOROURACIL + MITOMYCIN |
| 280005403 | 280003459 | 1.68 | 86.3 | Curative (C) | 2016-10-02 | 2016-10-17 | IVA | 2 | N | 280029040 | CAPECITABINE + OXALIPLATIN |
| 280005404 | 280003459 | 1.6 | 57.5 | Palliative (P) | 2017-07-28 | 2017-08-18 | Capecitabine (14 days)+Carboplatin | N | N | 280029040 | GEMCARBO |
| 280005405 | 280003459 | null | 62.4 | Neo-adjuvant (N) | 2015-08-14 | 2015-08-26 | CARBOPLATIN + FLUOROURACIL | null | N | 280029040 | ECX |
| 280005406 | 280003460 | 1.67 | 10.8 | Palliative (P) | 2017-02-06 | 2017-02-07 | MELPHALAN | 02 | Y | 280029044 | DACARBAZINE |
| 280005407 | 280003461 | 1.85 | 67.8 | Palliative (P) | null | 2016-11-23 | Cisplatin + Fluorouracil + RT 5day | Y | N | 280029045 | GEMCITABINE |
| 280005408 | 280003462 | 1.58 | 70.8 | Neo-adjuvant (N) | 2014-06-03 | 2014-06-14 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280029046 | DACARBAZINE |
| 280005409 | 280003462 | 1.62 | 93.25 | Palliative (P) | 2015-10-02 | 2015-10-05 | OCTREOTIDE | N | N | 280029046 | GEMCARBO |
| 280005410 | 280003462 | 1.59 | 59.4 | null | 2014-06-21 | 2014-07-17 | ECX | N | Y | 280029046 | CAPECITABINE + OXALIPLATIN |
| 280005411 | 280003462 | 1.81 | 86 | Curative (C) | 2014-10-11 | 2014-10-28 | Doxorubicin + Olaratumab | N | N | 280029046 | FLUOROURACIL + MITOMYCIN |
| 280005412 | 280003463 | 1.71 | 74.8 | Adjuvant (A) | 2014-11-20 | 2014-11-22 | Capecitabine (14 days)+Carboplatin | N | N | 280029052 | CISPLATIN + FLUOROURACIL + RT |
| 280005413 | 280003464 | null | 62.6 | null | 2015-08-30 | 2015-09-02 | Vemurafenib | null | null | 280029054 | GEMCITABINE |
| 280005414 | 280003465 | 1.88 | 125 | Palliative (P) | 2016-07-04 | 2016-07-17 | AXITINIB | N | N | 280029056 | CISPLATIN + ETOPOSIDE |
| 280005415 | 280007835 | 1.8 | 79 | Neo-adjuvant (N) | 2014-09-28 | 2014-10-13 | Capecitabine (21days) + Carboplatin | N | N | 280029057 | OCTREOTIDE |
| 280005416 | 280010000 | 1.95 | 95 | Not known (9) | 2015-09-27 | 2015-10-13 | CARBOPLATIN + VINORELBINE | N | N | 280029059 | LANREOTIDE |
| 280005417 | 280010000 | 1.6 | 77 | Palliative (P) | null | 2015-01-20 | VIDE | 02 | N | 280029059 | ECX |
| 280005418 | 280003466 | 1.65 | 65.4 | Palliative (P) | 2016-08-03 | 2016-08-04 | OCTREOTIDE | 02 | N | 280029061 | ECX |
| 280005419 | 280003466 | 1.7 | 54 | Palliative (P) | 2018-02-20 | 2018-02-26 | CARBOPLATIN + GEMCITABINE | 02 | N | 280029061 | GEMCITABINE |
| 280005420 | 280003467 | 1.62 | 51.5 | Palliative (P) | 2017-04-19 | 2017-04-19 | Doxorubicin + Olaratumab | N | N | 280029064 | SUNITINIB |
| 280005421 | 280007837 | null | 86.9 | Curative (C) | 2014-03-26 | 2014-03-27 | CETUXIMAB + CISPLATIN + FU | N | N | 280029065 | CAPECITABINE + OXALIPLATIN |
| 280005422 | 280007837 | 1.8 | 101.5 | Palliative (P) | 2013-05-22 | 2013-05-22 | LANREOTIDE | null | null | 280029065 | DACARBAZINE |
| 280005423 | 280003468 | null | 81.7 | Curative (C) | 2013-06-23 | 2013-06-23 | Gemcitabine weekly | N | null | 280029068 | CISPLATIN + VINORELBINE |
| 280005424 | 280003468 | 1.72 | 70.4 | Palliative (P) | 2015-03-26 | 2015-03-30 | AC | N | N | 280029068 | EC |
| 280005425 | 280003469 | null | null | Palliative (P) | 2017-11-08 | 2017-11-09 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | 2 | N | 280029070 | LANREOTIDE |
| 280005426 | 280003470 | 1.59 | 45.8 | Palliative (P) | 2009-03-02 | 2013-09-11 | Cisplatin + Pemetrexed | N | N | 280029073 | CAPECITABINE + OXALIPLATIN |
| 280005427 | 280003471 | 1.78 | 107.4 | Palliative (P) | 2013-07-12 | 2013-08-29 | CAPECITABINE + OXALIPLATIN | N | N | 280029076 | CARBOPLATIN + PEMETREXED |